Article Image
Ha Quoc Huy / File Photo

Neither New York State law nor Columbia’s policies mandate that college students receive a meningitis vaccination prior to enrollment.

Two cases of meningococcal disease have been diagnosed at the School of International and Public Affairs, University administrators announced this evening. Both students are being treated in St. Luke’s hospital, and the University is working with national health officials to continue prevention efforts.

Columbia is required by federal law to disclose cases of meningitis—a viral or bacterial inflammation of membranes around the spinal cord and brain—due to a potential public health risk. Those at increased risk for Meningitis B, which is one of the most common forms of Meningococcal disease, include infants, adolescents and young adults, and people in proximity to an outbreak. The disease is most commonly contracted through direct contact with bodily fluids, such as through sneezing and sharing drinks.

Neither New York State law nor Columbia’s policies mandate that college students receive a meningitis vaccination prior to enrollment. However, New York State does require that all university students receive information about the vaccine from their institution, and the University bars students from registering for classes until they have submitted proof of an Measles, Mumps, and Rubella vaccination and have made an informed decision regarding the meningitis vaccination.

While students may receive vaccinations around the ages of 11, 12, and 16, these vaccinations likely did not protect against Meningitis B, whose specific vaccines were licensed in 2014 and 2015. The vaccinations against Meningitis B—given at least one month apart—do not provide immediate protection but rather build long-term immunity. Starting next week, the University will release information about vaccine availability on campus.

Depending on the size of the population, two cases of meningitis may qualify as a public health crisis, according to the Centers for Disease Control and Prevention. The CDC also details outbreak control measures once an outbreak has been identified, which include vaccinating people at risk, and making sure all close contacts of a patient receives antibiotics. Columbia has identified those who may have been exposed and contacted them directly to offer them prophylactic antibiotics.

The email additionally outlined that government officials have deemed University events to be safe, but urged that students avoid sharing objects that come in contact with the mouth, such as eating utensils and towels. is

Read the full email below:

Dear Columbia Community:

We write to let you know that two members of the School of International and Public Affairs (SIPA) community were recently diagnosed with bacterial meningitis, caused by the meningococcal bacteria known as type B. They are currently hospitalized and are responding to treatment. We understand the great concern this causes. We are sharing information through this letter and the attached fact sheet to ensure that you understand the nature of this illness and the limited ways that transmission can occur, and also so you are fully aware of what we are doing to protect the health of our community. In speaking with them today, the Centers for Disease Control and Prevention (CDC) and local health officials recommend that activities on the Columbia University campus continue as normal.

Potential for Exposure

Close personal contacts (most commonly those who live in the household or who have spent extended periods of time with the ill individual) are sometimes advised to take preventative (prophylactic) antibiotic treatment. As such, Columbia Health is working closely with the city, state, and national health officials to get their guidance regarding such prophylaxis for the University community. We have already identified the individuals who may have been exposed and have contacted them directly to offer them prophylactic antibiotics.

About Meningitis

There are two general forms of meningitis: bacterial (usually Pneumococcal or Meningococcal) and viral (which can be caused by a host of viral agents). Bacterial meningitis is contagious, but generally is transmitted through direct exchange of respiratory and throat secretions by close personal contact, such as coughing, sharing drinks, kissing, and being in close proximity for an extended period. Fortunately, none of the bacteria that cause meningitis are as contagious as the common cold or the flu and they are not spread by casual contact or by simply breathing the air or being in the same building where a person with meningitis has been. Though extremely serious, bacterial meningitis can be effectively treated with intravenous antibiotics.


Signs and symptoms of bacterial meningitis could include high fever, headache, stiff neck, mental confusion, vomiting, feeling very tired, and a skin rash. The incubation period can vary from two to ten days, but on average is four days.


Vaccines to protect against meningococcal infection are available. The vaccine that most college students received when they were 11 or 12 years old and again at age 16 protects against four serogroups of meningococcal bacteria (A, C, W, Y). However, this vaccine does not provide protection against the strain of bacteria (serogroup B) that caused infection in these current students. Fortunately, two vaccines against serogroup B are now licensed in the United States (Bexsero® and Trumenba®) and offer protection against infection with this strain. Because these vaccines were recently licensed in 2014 and 2015, it is unlikely that many students have received them and are protected against serogroup B infection.

It generally takes 10 to 14 days for immunity to build after the first dose; the second dose in the vaccine series should be given at least one month after the initial dose. Therefore, the vaccine does not provide immediate protection but rather builds long-term immunity. Next week, we will provide information about vaccine availability on campus. Columbia University will follow recommendations given by local, state, and national healthcare officials around community vaccination.

More Information

Columbia Health is encouraging members of the University community to pay increased attention to personal hygiene practices in light of these confirmed cases. Helpful precautions include:

Always coughing into a sleeve or tissue, washing hands frequently, and using hand sanitizer often. Not sharing drinking glasses, cigarettes, other smoking material, eating utensils, or drinking from a common source, such as a punch bowl.

Read more about bacterial meningitis and precautions on Columbia Health’s website. More information is available on the Centers for Disease Control and Prevention website and the New York State Department of Health website. A fact sheet is also attached.

Members of the University community who experience symptoms or have health concerns may contact Columbia Health at 212-854-7426.

Thank you for your attention to this important matter.

With care for our community,

Melanie Bernitz, MD, MPH

Associate Vice President and Medical Director, Columbia Health

Associate Clinical Professor of Medicine (in the Center for Family and Community Medicine)

News editor Karen Xia can be contacted at Follow her on Twitter @xia_karen.

Managing Editor of The Eye Julian Shen-Berro can be contacted at Follow him on Twitter @julianshenberro.

Meningitis B Meningococcal bacteria Columbia Health Centers for Disease Control and Prevention
Related Stories